Bavarian Nordic – transaktioner i forbindelse med aktietilbagekøbsprogram
January 20, 2025 01:30 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 20. januar 2025 – Bavarian Nordic A/S (OMX: BAVA) offentliggør transaktioner under aktietilbagekøbsprogrammet, der blev iværksat den 9. januar 2025, hvorunder selskaber vil...
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
January 20, 2025 01:30 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, January 20, 2025 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on January 9, 2025, under which the Company will repurchase...
Bavarian Nordic lancerer planlagt aktietilbagekøbsprogram for DKK 150 mio.
January 09, 2025 02:09 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 9. januar 2025 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at selskabet iværksætter et aktietilbagekøbsprogram for op til DKK 150 mio. som meddelt den 11. december 2024....
Bavarian Nordic Launches Planned Share Buy-Back Program of DKK 150 Million
January 09, 2025 02:09 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, January 9, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today the initiation of a share buy-back program of up to DKK 150 million as announced on December 11, 2024. The...
Bavarian Nordic indgår licens- og produktionsaftale omkring mpox-vaccine med Serum Institute of India
December 16, 2024 01:30 ET
|
Bavarian Nordic A/S
En teknologioverførsel for MVA-BN® bidrager til at øge den globale produktionskapacitet for mpox-vaccinen samt til yderligere at øge adgangen til vaccinen for udsatte befolkningsgrupper.Serum...
Bavarian Nordic Enters License and Manufacturing Agreement for its Mpox Vaccine with Serum Institute of India
December 16, 2024 01:30 ET
|
Bavarian Nordic A/S
Tech transfer of MVA-BN® will help increase global mpox vaccine manufacturing capacity and further expand the equitable access to vulnerable populations.Serum Institute of India obtains license to...
Indberetning af ledende medarbejdere og disses nærtståendes transaktioner med Bavarian Nordic aktier og tilknyttede værdipapirer
December 13, 2024 11:30 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 13. december 2024 – Bavarian Nordic A/S (OMX: BAVA) har dags dato modtaget oplysninger om følgende transaktioner med selskabets aktie/tilknyttede værdipapirer, foretaget af ledende...
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
December 13, 2024 11:30 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, December 13, 2024 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding...
Bavarian Nordic iværksætter nyt incitamentsprogram for koncernledelsen og udvalgte medarbejdere
December 13, 2024 02:00 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 13. december 2024 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at bestyrelsen har besluttet at etablere et nyt langsigtet incitamentsprogram for koncernledelsen og udvalgte...
New Incentive Program Established for Members of Executive Management and Selected Employees in Bavarian Nordic
December 13, 2024 02:00 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, December 13, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Board of Directors has decided to establish a new long-term incentive program for Executive Management...